Ciclopirox
Above: molecular structure of ciclopirox
Below: 3D representation of a ciclopirox molecule | |
| Clinical data | |
|---|---|
| Trade names | Penlac Nail Lacquer, others[1] |
| Other names | Loprox, CPX |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a604021 |
| License data |
|
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | <5% with prolonged use |
| Protein binding | 94 to 97% |
| Elimination half-life | 1.7 hours |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.045.056 |
| Chemical and physical data | |
| Formula | C12H17NO2 |
| Molar mass | 207.273 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Ciclopirox is a medication used for the treatment of moderate onychomycosis of fingernails and toenails,[3] and for the treatment of seborrheic dermatitis.[4]
In 2022, it was the 247th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[5][6]
- ^ Cite error: The named reference
brandswas invoked but never defined (see the help page). - ^ "Penlac Nail Lacquer (ciclopirox) Topical Solution, 8%". DailyMed. Retrieved 2 December 2024.
- ^ a b Cite error: The named reference
Ciclodan FDA labelwas invoked but never defined (see the help page). - ^ a b Cite error: The named reference
Loprox FDA labelwas invoked but never defined (see the help page). - ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
- ^ "Ciclopirox Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.